Each year here in West Virginia, the Greenbrier Clinic, where I have my yearly physical, sends me a complete list of my vaccinations and when the boosters are due. I make every effort to stay current with them because having chronic obstructive pulmonary disease (COPD) makes me vulnerable…
A Phase 2 trial designed to test a self-administered inhaled formulation of nitric oxide (NO) for adults with chronic obstructive pulmonary disease (COPD), or bronchiectasis, is recruiting eligible patients. The formulation, called RESP301, is a liquid solution that, once inhaled through a nebulizer, releases NO into the lungs. RESP301 was…
AB569, Arch Biopartners’ lead therapy candidate, has received a U.S. patent for the treatment of chronic lung infections in patients with chronic obstructive pulmonary disease (COPD) or cystic fibrosis. Patent 9,925,206 was issued by the U.S. Patent and Trademark Office to the University of Cincinnati, which previously granted…
In this video from Novartis, several COPD patients talk about their lives with the disease and how frequent chest infections have affected them. Read our six tips for protecting your lungs. From pleurisy to pneumonia, the patients featured have all suffered a variety of chest infections that have negatively…
A collaborative research study between several Australian institutions suggests that cigarette smoking and infection with viruses such as influenza can reduce the effectiveness of symptom-reliever drugs like salbutamol in patients with chronic obstructive pulmonary disease (COPD). These findings were published in a research article, “Influenza A virus…
Get regular updates to your inbox.